|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.300 USD | +2.22% |
|
+4.55% | +100.00% |
| 06-29 | Lexicon Pharmaceuticals, Inc.(NasdaqCM:LXRX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Lexicon Pharmaceuticals, Inc.(NasdaqCM:LXRX) added to Russell 2000 Index | CI |
| Market Cap | 999M 878M 816M 751M 1.41B 96.51B 1.43B 9.73B 3.8B 47.13B 3.75B 3.67B 164B | P/E 2026 * |
-14.3x | P/E 2027 * | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 999M 878M 816M 751M 1.41B 96.51B 1.43B 9.73B 3.8B 47.13B 3.75B 3.67B 164B | EV / Sales 2026 * |
26.2x | EV / Sales 2027 * | 49.6x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | +2.22% | ||
| 1 week | +4.55% | ||
| Current month | -4.17% | ||
| 1 month | +6.98% | ||
| 3 months | +26.37% | ||
| 6 months | +30.68% | ||
| Current year | +100.00% |
| 1 week | 2.19 |  | 2.42 |
| 1 month | 2.04 | | 2.68 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/3/26 A | Fiscal year | Director | 178,624 | 0.0402% | ||
| 6/3/26 A | Fiscal year | Director | 178,624 | 0.0402% | ||
| 6/3/26 A | Fiscal year | Chairman | 178,624 | 0.0402% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.22% | +4.55% | +91.67% | +10.58% | 999M | |
| +1.23% | -3.08% | +53.96% | +87.98% | 55.27B | |
| +5.09% | +6.18% | +63.69% | +62.06% | 54.15B | |
| +0.72% | -2.19% | +4.36% | +409.54% | 23.11B | |
| +0.25% | +0.08% | -17.39% | -15.22% | 23.22B | |
| +1.03% | -0.76% | +40.14% | -3.59% | 20.33B | |
| -0.37% | +0.42% | +37.47% | -31.61% | 17.91B | |
| +0.87% | -2.80% | +37.96% | +600.00% | 15.76B | |
| -2.54% | -12.88% | +168.62% | +289.45% | 15B | |
| +1.22% | +0.18% | +25.14% | +182.63% | 13.82B | |
| Average | +0.97% | -0.11% | +50.56% | +159.18% | 23.96B | |
| Weighted average by Cap. | +1.57% | +1.19% | +46.67% | +137.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.17M 33.55M 31.17M 28.67M 53.75M 3.69B 54.78M 372M 145M 1.8B 143M 140M 6.25B | 20.15M 17.71M 16.46M 15.14M 28.38M 1.95B 28.93M 196M 76.65M 950M 75.65M 74.02M 3.3B |
| Net income | -66.94M -58.83M -54.66M -50.27M -94.26M -6.46B -96.07M -652M -255M -3.16B -251M -246M -10.97B | -88.26M -77.58M -72.08M -66.29M -124M -8.52B -127M -860M -336M -4.16B -331M -324M -14.46B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/07/26 | $2.305 | +2.44% | 2,705,888 |
| 22/07/26 | $2.250 | -5.46% | 3,601,885 |
| 21/07/26 | $2.380 | +2.15% | 2,348,814 |
| 20/07/26 | $2.330 | -2.51% | 3,095,660 |
| 17/07/26 | $2.390 | +6.70% | 2,431,579 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
